These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 26879237

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
    Järvinen K, Hoehe W, Järvinen M, Poutiainen S, Juuti M, Borchert S.
    Eur J Pharm Sci; 2013 Mar 12; 48(4-5):680-8. PubMed ID: 23313622
    [Abstract] [Full Text] [Related]

  • 4. Real-time monitoring of pharmaceutical properties of medical tablets during direct tableting process by hybrid tableting process parameter-time profiles.
    Saito S, Hattori Y, Sakamoto T, Otsuka M.
    Biomed Mater Eng; 2020 Mar 12; 30(5-6):509-524. PubMed ID: 31771033
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous manufacturing and process analytical tools.
    Maniruzzaman M, Douroumis D.
    Int J Pharm; 2015 Dec 30; 496(1):1-2. PubMed ID: 26647292
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing.
    Janssen PHM, Fathollahi S, Dickhoff BHJ, Frijlink HW.
    Expert Opin Drug Deliv; 2024 Jul 30; 21(7):1069-1079. PubMed ID: 39129595
    [Abstract] [Full Text] [Related]

  • 9. Prediction of tablet properties based on near infrared spectra of raw mixed powders by chemometrics: Scale-up factor of blending and tableting processes.
    Otsuka M, Yamane I.
    J Pharm Sci; 2009 Nov 30; 98(11):4296-305. PubMed ID: 19530073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recent progress in continuous manufacturing of oral solid dosage forms.
    Vanhoorne V, Vervaet C.
    Int J Pharm; 2020 Apr 15; 579():119194. PubMed ID: 32135231
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Manufacturing process transfer to a 30 kg/h continuous direct compression line with real-time composition monitoring.
    Waněk A, Menarini L, Giatti F, Kubelka T, Consoli F, Funaro C, Stasiak P, Štěpánek F.
    Int J Pharm; 2024 May 10; 656():124100. PubMed ID: 38609059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.